BGLC
BioNexus Gene Lab·NASDAQ
--
--(--)
--
--(--)
BGLC fundamentals
BioNexus Gene Lab (BGLC) released its earnings on Nov 20, 2023: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Nov 20, 2023
EPS
Actual | |
Forecast | |
Surprise | 0.00% |
Revenue
Actual | -- |
Forecast | -- |
Surprise | 0.00% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for BioNexus Gene Lab next quarter?What is the revenue and EPS growth rate for BioNexus Gene Lab year over year?Did BioNexus Gene Lab beat or miss consensus estimates last quarter?What factors drove the changes in BioNexus Gene Lab's revenue and profit?What guidance did BioNexus Gene Lab's management provide for the next earnings period?What were the key takeaways from BioNexus Gene Lab’s earnings call?What is BioNexus Gene Lab's gross profit margin?What were the key takeaways from BioNexus Gene Lab's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
